Surgical procedures for benign prostatic hyperplasia: A nationwide survey in Japan

Similar documents
Index. urologic.theclinics.com. Note: Page numbers of article titles are in boldface type.

Chapter 2: Methodology

Benign Prostatic Hyperplasia (BPH)

Consensus Meeting for Asian-Pacific BPH Guideline

POLICIES AND PROCEDURE MANUAL

Treating BPH: Comparing Rezum UroLift and HoLEP

What is Benign Prostatic Hyperplasia (BPH)?

Rezūm procedure for the Prostate

Executive Summary. Non-drug local procedures for treatment of benign prostatic hyperplasia 1. IQWiG Reports - Commission No.

MODULE 3: BENIGN PROSTATIC HYPERTROPHY

NOTE: This policy is not effective until April 1, Transurethral Water Vapor Thermal Therapy of the Prostate

Comparison of outpatient versus inpatient transurethral prostate resection for benign prostatic hyperplasia: Comparative, prospective bi-centre study

Index. urologic.theclinics.com. Note: Page numbers of article titles are in boldface type.

Surgical Treatment of LUTS in Men with BPE

AMERIHEALTH / INDEPENDENCE BLUE CROSS

Early-Stage Clinical Experiences of Holmium Laser Enucleation of the Prostate (HoLEP)

Management of LUTS after TURP and MIT

Energy Delivery Systems for Treatment of Benign Prostatic Hyperplasia

BENIGN PROSTATIC HYPERPLASIA (BPH) affects 70%

Korean Urologist s View of Practice Patterns in Diagnosis and Management of Benign Prostatic Hyperplasia: A Nationwide Survey

Original Policy Date

Benign Prostatic Hyperplasia: Update on Innovative Current Treatments

EAU GUIDELINES POCKET EDITION 3

Transurethral Laser Technology: Treatments for BPH

50% of men. 90% of men PATIENT FACTSHEET: BPH CONDITION AND TREATMENTS. Want more information? What are the symptoms?

Submitted: August 15, Accepted: September 10, Published: October 15, 2018.

GUIDELINES ON NON-NEUROGENIC MALE LUTS INCLUDING BENIGN PROSTATIC OBSTRUCTION (BPO)

Citation Acta medica Nagasakiensia. 1997, 42

Clinical Policy Title: Management of benign prostatic hyperplasia (BPH)

Department of Urology, Nippon Medical School Chiba Hokusou Hospital, Chiba, Japan. Department of Urology, Nippon Medical School, Tokyo, Japan

Transition in Type of Surgery for Benign Prostatic Hyperplasia: A Multi-institutional Study in Japan

Clinical guideline Published: 23 May 2010 nice.org.uk/guidance/cg97

Benign Prostatic Hyperplasia (BPH):

NATIONAL INSTITUTE FOR HEALTH AND CLINICAL EXCELLENCE

Initial Experience of High Power Diode Laser for Vaporization of Prostate Muhammad Rafiq Zaki, Mujahid Hussain, Tahir Mehmood, Murtaza Hiraj

Lasers in Urology. Laser Tissue Interaction, November 28 th, Qureshi, Muhammad Mohsin. Biomedical in vivo Opto-scopy Laboratory

Lasers in Urology. An Evidence-Based Approach to Choosing the Right Tool

EAU GUIDELINES ON NON- NEUROGENIC MALE LUTS INCLUDING BENIGN PROSTATIC OBSTRUCTION

GUIDELINES ON NON-NEUROGENIC MALE LUTS INCLUDING BENIGN PROSTATIC OBSTRUCTION

The impact of minimally invasive surgeries for the treatment of symptomatic benign prostatic hyperplasia on male sexual function: a systematic review

Overview. Urology Dine and Learn: Erectile Dysfunction & Benign Prostatic Hyperplasia. Iain McAuley September 15, 2014

Name of Policy: Transurethral Microwave Thermotherapy

HOLMIUM:YAG LASER WHEN POWERFUL VERSATILITY INTEGRATES UNMATCHED PRECISION.

The Enlarged Prostate Symptoms, Diagnosis and Treatment

Benign Prostatic Hyperplasia (BPH) Treatments

EFFICACY OF LASER SURGERY FOR BENIGN PROSTATIC HYPERPLASIA TREATMENT

EAU GUIDELINES ON NON- NEUROGENIC MALE LUTS INCLUDING BENIGN PROSTATIC OBSTRUCTION

Benign prostatic hyperplasia (BPH)

HOLMIUM:YAG LASER WHEN POWERFUL VERSATILITY INTEGRATES UNMATCHED PRECISION. Main Application Fields UROLOGY GENERAL SURGERY ENT

Prostate Artery Embolization

PROSTATIC ARTERY EMBOLISATION (PAE) FOR BENIGN PROSTATIC HYPERPLASIA. A Minimally Invasive Innovative Treatment

Wednesday 25 June Poster Session 9: BPH 1 Chairmen: M. Speakman and D. Rosario

Control & confidence. You deserve both. YOUR GUIDE TO THE TREATMENT OF BPH

Control & confidence. You deserve both.

European Urology 44 (2003) 89 93

PROSTATIC EMBOLIZATION FOR BENIGN HYPERPLASIA

REVIEW ARTICLES. Infravesical urinary tract obstruction and transurethral endoscopic approach of treatment

Yong Taec Lee, Young Woo Ryu, Dong Min Lee, Sang Wook Park, Seung Hee Yum, June Hyun Han

LASER PROSTATECTOMY AND ITS PLACE IN THE THIRD WORLD

TITLE: Plasma Vaporization of the Prostate for Treatment of Benign Prostatic Hypertrophy: A Review of Clinical and Cost-Effectiveness, and Safety

Early outcome of transurethral enucleation and resection of the prostate versus transurethral resection of the prostate

ECONOMIC EVALUATION OF TREATMENT FOR BENIGN PROSTATIC HYPERPLASIA -TRANSURETHRAL RESECTION VS THERMOTHERAPY VS LASER VAPORIZATION-

REPORTS. Clinical and Economic Outcomes in Patients Treated for Enlarged Prostate

Number: Policy *Please see amendment for Pennsylvania Medicaid at the end of

Policy for Prostatism/Lower Urinary Tract Symptoms in men

Chapter 3: Results of the Treatment Outcomes Analyses

Thulium Laser versus Standard Transurethral Resection of the Prostate: A Randomized Prospective Trial

Transurethral Hot Water Balloon Thermotherapy for Benign Prostatic Hyperplasia

All about the Prostate

How Do New Data from Clinical Trials Allow Us to Optimise the Assessment and Treatment of Patients with Benign Prostatic Hyperplasia?

Lasers in Urology. Sae Woong Choi, Yong Sun Choi, Woong Jin Bae, Su Jin Kim, Hyuk Jin Cho, Sung Hoo Hong, Ji Youl Lee, Tae Kon Hwang, Sae Woong Kim

Review Article BPH Procedural Treatment: The Case for Value-Based Pay for Performance

GENDER HEALTH. Benign Prostatic Hyperplasia. Medical and Surgical Treatment Options

Holmium Laser Enucleation of the Prostate: Modified Morcellation Technique and Results

OUTCOMES OF HoLEP IN THE RETREATMENT SETTING

Original article A comparative study of two surgical approaches of Benign Prostatic Hyperplasia in a tertiary care teaching hospital.

Introduction. Original Article: Clinical Investigation. Yosuke Hirasawa, 1 Yuji Kato 2 and Kiichiro Fujita 2

Information for Patients. Benign Prostatic Enlargement. English

ISPUB.COM. Photoselective Vaporisation of the Prostate - Independent Surgical Experience Following Comprehensive Resident Training in the Technique.

Randomized, controlled trial of laser vs. bipolar plasma vaporization treatment of benign prostatic hyperplasia

Chapter 3: Results of the Treatment Outcomes Analyses

YOUR CHOICE FOR BPH Resection, Vaporization, Enucleation Individual PLASMA Treatment

Combination of Thulium Laser Incision and Bipolar Resection Offers Higher Resection. Velocity than Bipolar Resection Alone in Large Prostates

Diode Laser Treatment of Human Prostates

Technique and Short-Term Outcome of Green Light Laser (KTP, 80 W) Vaporisation of the Prostate

Roberto Giulianelli, Barbara Gentile, Luca Albanesi, Paola Tariciotti, and Gabriella Mirabile

PATIENT INFORMATION 2017 NeoTract, Inc. All rights reserved. Printed in the USA. MAC Rev A

Service Line: Rapid Response Service Version: 1.0 Publication Date: March 01, 2017 Report Length: 16 Pages

Prostatic Urethral Lift. Summary

Medical Policy Benign Prostatic Hypertrophy

Benign prostatic hyperplasia (BPH) is one of the

PREDICTORS OF ENUCLEATION AND MORCELLATION TIME DURING HOLMIUM LASER ENUCLEATION OF THE PROSTATE

980-nm Diode Laser: A Novel Laser Technology for Vaporization of the Prostate

OVER 70% OF MEN IN THEIR 60s HAVE SYMPTOMS OF BPH 1

Public Statement: Medical Policy Statement:

SURGICAL MANAGEMENT OF BPH IN GHANA: A NEED TO IMPROVE ACCESS TO TRANSURETHRAL RESECTION OF THE PROSTATE

A Critical Evaluation of MIST Intervention in LUTS and BPH Treatment

Transcription:

International Journal of Urology (2011) 18, 166 170 doi: 10.1111/j.1442-2042.2010.02687.x Short Communicationiju_2687 166..170 Surgical procedures for benign prostatic hyperplasia: A nationwide survey in Japan Naoya Masumori, 1 Toshiyuki Kamoto, 2 Narihito Seki 3 and Yukio Homma 4 on behalf of the Committee for Clinical Guideline for Benign Prostatic Hyperplasia 1 Department of Urology, Sapporo Medical University School of Medicine, Sapporo, Hokkaido, 2 Department of Urology, Faculty of Medicine, University of Miyazaki, Miyazaki, 3 Department of Urology, Kyushu University, Fukuoka, and 4 Department of Urology, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan Abstract: We investigated the trend in surgical procedures for benign prostatic hyperplasia (BPH) during the past 10 years in Japan. A questionnaire inquiring about the number of operations and surgical procedures for BPH in 1999, 2004 and 2009 was sent to 1824 institutes belonging to the Japanese Urological Association and/or the Japanese Clinical Urologists Association. Responses were obtained from 767 institutes (42.1%). The number of operations showed a gradual increase during the 10 years (n = 17 221 in 1999, 18 772 in 2004, 20 413 in 2009). Transurethral resection of the prostate, including transurethral resection in saline, was consistently the most common procedure (72.5% to 79.2%). Holmium laser enucleation of the prostate and transurethral enucleation with a bipolar system have dramatically increased, becoming the second most common in 2009 (n = 3416), although enucleation by open prostatectomy was still a viable option in 2009 (n = 555). Photoselective vaporization of the prostate was the third most common method in 2009 (n = 572). Coagulation and thermotherapy have become uncommon (n = 2039 in 1999, 217 in 2009), whereas incision and stenting were unchanged during the period. Thus, surgical procedures for BPH have been increasing in Japan during the past decade. Transurethral resection remains the standard, whereas enucleation and vaporization have been increasing. Key words: benign prostatic hyperplasia, nationwide survey, surgery. Introduction There are several treatment options for benign prostatic hyperplasia (BPH), including watchful waiting, behavioral therapy, medical treatment and surgical treatment, including open and endoscopic prostatectomy. 1,2 Surgical treatment is definitely more effective in improving lower urinary tract symptoms (LUTS) and urinary flow rate than medical treatment. There are very many methods, including incision, resection, enucleation, coagulation and vaporization, as well as the use of energies, such as mechanical force, high frequency current, microwaves, radiowaves, ultrasound, the potassium laser and the holmium laser. 1,2 Seki et al. 3 carried out a survey to evaluate the prevalence of and preference for surgical treatment for BPH in 2000. However, there is no statistical information available in Japan after their survey. Some procedures might lose popularity and others gain popularity through innovation, progress and widespread use of various surgical techniques. In addition, the changes in socioeconomic status and patients attitudes regarding valuing their quality of life might influence the indication Correspondence: Naoya Masumori M.D., Department of Urology, Sapporo Medical University School of Medicine, Sapporo 060-8543, Japan. Email: masumori@sapmed.ac.jp Received 13 September 2010; accepted 11 November 2010. Online publication 22 December 2010 for surgery and its type. In the present study, we investigated the trend in surgical procedures for BPH during the past 10 years in Japan. The study was carried out as an official research project of the Japanese Urological Association (JUA). A questionnaire inquiring about the number of operations by surgical procedures for BPH from 1 January to 31 December in 1999, 2004 and 2009 was mailed to 1824 urological institutes in Japan in February 2010. Of these institutes, 1189 and 635 belonged to the JUA (mainly academic, educational or referral hospitals) and the Japanese Clinical Urologists Association (JCUA, mainly private clinics), respectively. The types of surgical procedures asked about in the questionnaire are listed in Table 1. In addition, we inquired about the most suitable surgical procedure according to estimated prostate volume (PV). Results The overall response rate was 42.1% (767/1824). The response rate was higher for members of the JUA (48.0%, 572/1189) than for JCUA members (30.7%, 195/635). Replies were obtained from members in all 47 prefectures in Japan. 166 2010 The Japanese Urological Association

Nationwide survey on BPH surgery in Japan Table 1 Enucleation Resection Vaporization Coagulation Incision Thermotherapy Injection Indwelling Others Surgical procedures inquired about in the survey Surgical procedure Open retropubic/suprapubic prostatectomy Transurethral detachment prostatectomy (Hiraoka s method) Transurethral enucleation with bipolar (TUEB) Holmium laser enucleation of the prostate (HoLEP) Transurethral resection of the prostate (TURP) Transurethral resection in saline (TURis) Transurethral vapor-resection of the prostate using a thick wedge loop (TUVRP) Holmium laser resection of the prostate (HoLRP) Transurethral vaporization of the prostate (TUVP/TURisV) Visualized laser ablation of the prostate (VLAP, Nd: YAG) Holmium laser ablation of the prostate (HoLAP) Photoselective vaporization of the prostate (PVP, KTP) Interstitial laser coagulation of the prostate (ILCP) Transurethral needle ablation (TUNA) Transurethral incision of the prostate (TUIP) Transurethral laser incision the prostate (TULIP) Transurethral microwave thermotherapy (TUMT) Transurethral balloon laser thermotherapy (TUBAL-T) Transurethral radiofrequency heating (TURF) High-intensity focused ultrasound (HIFU) Botulinum toxin Ethanol Permanent urethral stent Table 2 Institute The number of operations in each year by institute Year 1999 2004 2009 JUA 14 928 (86.7) 17 173 (91.5) 18 905 (92.6) JCUA 2 293 (13.3) 1 599 (8.5) 1 508 (7.4) Total 17 221 (100) 18 772 (100) 20 413 (100) Number of operations (%). JCUA, Japanese Clinical Urologists Association; JUA, Japanese Urological Association. The number of operations showed a gradual increase during the 10 years (Table 2). It increased among the members of the JUA, whereas a decreasing tendency was observed among the members of the JUCA. Transurethral resection of the prostate (TURP) was consistently the most common procedure in each year (Table 3). A surge of transurethral resection in saline (TURis) was observed in 2009. Holmium laser enucleation of the prostate (HoLEP) or transurethral enucleation with a bipolar (TUEB) system has dramatically increased to become the second most common procedure in 2009, although enucleation by open prostatectomy was still a viable option in 2009. Photoselective vaporization of the prostate (PVP) has replaced visualized laser ablation of the prostate (VLAP). Coagulation using interstitial laser coagulation of the prostate (ILCP) and transurethral needle ablation (TUNA) has become uncommon. Although over 1000 of transurethral microwave thermotherapy (TUMT) procedures were carried out in 1999, the number rapidly decreased in 2009. Incision and stenting were unchanged during the period. If PV was < 20 ml, 8% reported that there was no surgical indication (Table 4). However, if surgery was considered, resection was the most frequent answer throughout the range of PV. Incision was only indicated for men with PV < 20 ml. The proportion of resections decreased with the increase of PV, conversely, the proportion of open prostatectomy increased. If PV was 100 ml or over, open prostatectomy was most often selected, followed by resection and enucleation other than open prostatectomy. Discussion This survey was carried out for 1824 institutes belonging to the JUA and JCUA in Japan. Although the response rate was 42%, it is the largest series to show the number of operations 2010 The Japanese Urological Association 167

N MASUMORI ET AL. Table 3 The number of operations in each year by surgical methods and procedures Procedures Year 1999 2004 2009 Enucleation Open 709 1 224 555 Hiraoka s method 121 150 223 TUEB 0 0 808 HoLEP 41 291 2 608 Subtotal 871 1 665 4 194 Resection TURP 12 904 14 624 12 094 TURis 160 252 2 494 TUVRP 401 356 162 HoLRP 72 50 52 Subtotal 13 537 15 282 14 802 Vaporization TUVP/TURisV 132 58 191 VLAP 210 19 0 HoLAP 0 105 67 PVP 1 15 314 Subtotal 343 197 572 Coagulation ILCP 295 118 2 TUNA 374 52 0 Subtotal 669 170 2 Incision TUIP 186 179 239 Thermotherapy TULIP 1 2 0 TUMT 1 218 660 151 TUBAL-T 85 7 0 TURF 84 22 9 HIFU 42 78 55 Subtotal 1 430 769 215 Injection Botulinum 0 10 6 Ethanol 0 10 0 Subtotal 0 20 6 Indwelling Stent 184 489 382 Others 1 1 1 Total 17 221 18 772 20 413 HIFU, high-intensity focused ultrasound; HoLAP, holmium laser ablation of the prostate; HoLEP, holmium laser enucleation of the prostate; ILCP, interstitial laser coagulation of the prostate; PVP, photoselective vaporization of the prostate; TUBAL-T, transurethral balloon laser thermotherapy; TUEB, transurethral enucleation with bipolar; TUIP, Transurethral incision of the prostate; TULIP, transurethral laser incision the prostate; TUMT, transurethral microwave thermotherapy; TUNA, transurethral needle ablation; TURF, transurethral radiofrequency heating; TURis, transurethral resection in saline; TURP, transurethral resection of the prostate; TUVP/TURisV; transurethral vaporization of the prostate VLAP, visualized laser ablation of the prostate. according to surgical procedures for BPH in Japan. Because not only academic hospitals but also private clinics replied, the results seem to be representative of the actual clinical condition in Japan. According to the survey, the number of operations showed a gradual increase during the 10 years. Introduction of new medical treatments might affect the number of operations by influencing the indication for surgery. The years investigated in this survey, 1999, 2004 and 2009, were in the a1-blocker era. A 5-alpha reductase inhibitor became available at the end of 2009 in Japan, so it is unlikely that the launching of the drug influenced the statistics in 2009. Although the reasons for the surgical indication are unknown in the survey, the increasing number of operations might reflect the increased availability of new technologies with less invasiveness, as well as the increased number of the elderly population in Japan during the 10 years. 4 The survey showed that TURP was the most frequent procedure, even in 2009. It seems that most urologists actively doing surgery are familiar with conventional TURP using a resectscope with a loop electrode. However, 168 2010 The Japanese Urological Association

Nationwide survey on BPH surgery in Japan Table 4 The most suitable surgical procedure according to estimated prostate volume answered by 633 institutes Estimated prostate volume (ml) <20 20 49 50 79 80 99 100 Open prostatectomy 0 0 25 (3.9) 152 (24.0) 292 (46.1) Enucleation other than open prostatectomy 41 (6.5) 73 (11.5) 112 (18.0) 118 (18.6) 111 (17.5) Resection 494 (72.5) 533 (84.2) 479 (75.7) 333 (52.6) 199 (31.4) Vaporization 15 (2.4) 16 (2.5) 11 (1.0) 11 (1.0) 8 (1.3) Incision 26 (4.1) 0 0 0 0 Other 7 (1.1) 4 (0.6) 2 (0.3) 3 (0.5) 3 (0.5) No indication for surgery 50 (7.9) 6 (0.9) 0 0 0 Refer to other hospitals 0 1 (0.2) 4 (0.6) 16 (2.5) 20 (3.2) Total number of institutes 633 (100) 633 (100) 633 (100) 633 (100) 633 (100) Number of institutes (%), Others included interstitial laser coagulation of the prostate, transurethral microwave thermotherapy, ethanol injection and stenting. considering the recent rapid increase in the number of bipolar TURP operations using saline instead of sorbitol solution for irrigation (TURis, etc.), it might replace conventional TURP in the future, because of its low incidence of development of dilutional hyponatremia. 5 Another remarkable change observed in the survey was the increased number of enucleations, especially those carried out by HoLEP. There are many reports showing the efficacy and safety of HoLEP using an 80 100 W of holmium laser. 6 It can be applicable for prostates of 100 ml or larger, which are not usually indicated for TURP. However, the high prices of the generator and the morcellator might prevent the widespread utilization of the procedure. This survey showed an increased number of TUEB procedures using a spatula for mechanical enucleation of adenoma in 2009. Although evidence for the efficacy and safety is poor, it might become more popular as a method of enucleation because of the low price of the apparatus. Vaporization is a safe surgical procedure that can achieve coagulation of the prostatic cavity. VLAP using the Nd : YAG laser completely disappeared in 2009; instead, PVP using the KTP laser increased. As a result of the shorter optical penetration of the KTP laser than the Nd : YAG laser, the incidences of severe dysuria and delayed sloughing were lower for PVP than for VLAP. 7 Although PVP has efficacy comparable to TURP with fewer complications, the generator and the laser fiber have not yet been approved in Japan. Transurethral vaporization of the prostate (TURisV) using a mushroom-shaped electrode for vaporization with high frequency current might be promising, because the expensive generator is not necessary. The dramatically decreased numbers of procedures with coagulation and thermotherapy might reflect the dissatisfaction of urologists and patients with the efficacy, despite the decreased invasiveness. Significant reductions of the medical fees for coagulation and thermotherapy in 2004 and 2006 might also have contributed to the decrease in these procedures. Incision still survives, because it is applied to patients with prostates smaller than 20 ml. Stenting, which is not a surgical procedure in reality, has been constantly used. It might be indicated for aged patients unfit for surgical treatment as a result of comorbidity, for example. In the survey, approximately 500 patients were still managed by open prostatectomy in 2009. PV was a determinant of the indication for open prostatectomy. For the patients with PV of 100 ml or over, open prostatectomy was indicated in 46% of the institutes. With the widespread use of HoLEP and so on, the number of open prostatectomies might decrease in the future. It is interesting that TURP was indicated for patients with large prostates in 31% of the institutes. Thus, the upper limit of PV endoscopically manageable is definitely different among institutes and surgeons. In conclusion, surgical procedures for BPH have been increasing in Japan during the past decade. Transurethral resection remains the standard, whereas enucleation and vaporization have been increasing. Acknowledgments We thank all members of the JUA and the JCUA who replied to the questionnaire and the committee for clinical guidelines of benign prostatic hyperplasia (Momokazu Gotoh, Yukio Homma, Osamu Ishizuka, Toshiyuki Kamoto, Akihiro Kawauchi, Naoya Masumori, Atsushi Nagai, Seiichiro Ozono, Narihito Seki, Tomonori Yamanishi and Osamu Yokoyama). References 1 Roehrborn CG, McConnell JD, Barry MJ et al. AUA Guideline on the Management of Benign Prostatic Hyperplasia. [Cited 2 December 2010.] Available from URL: 2010 The Japanese Urological Association 169

N MASUMORI ET AL. http://www.auanet.org/content/guidelines-and-quality-care/ clinical-guidelines.cfm?sub=bph&cfid=429170&cftoken =27644870&jsessionid=84301422c614a2e7c3b57e1b7a242a 594471 2 de la Rosette J, Alivizatos S, Maderbacher S et al. Guidelines on Benign Prostatic Hyperplasia. [Cited 2 December 2010.] Available from URL: http://www.uroweb. org/fileadmin/tx_eauguidelines/2004/full/bph_2004.pdf 3 Seki N, Naito S, Oshima S et al. Prevalence and preference with regard to various surgical treatments for benign prostatic hypertrophy: a survey for the Japanese endourology and ESWL society member. Jpn J. Urol. 2003; 94: 495 502. 4 The Statistics Bureau and the Director-General for Policy Planning of Japan. Koreisha no jinko. [Cited 2 December 2010.] Available from URL: http://www.stat.go.jp/data/ topics/topi481.htm 5 Thiel DD, Petrou SP. Electroresection and open surgery. Urol. Clin. North Am. 2009; 36: 461 70. 6 Lerner LB, Tyson MD. Holmium laser applications of the prostate. Urol. Clin. North Am. 2009; 36: 485 95. 7 Wosnitzer MS, Rutman MP. KTP/LBO laser vaporization of the prostate. Urol. Clin. North Am. 2009; 36: 471 83. 170 2010 The Japanese Urological Association